US equities
|
MU
$1,035.80
▼-4.80%
NVDA
$230.42
▼-2.97%
SNDK
$1,592.55
▼-5.90%
AMD
$616.74
▼-4.51%
INTC
$106.89
▼-5.51%
SPCX
$161.54
▼-3.61%
META
$719.73
▼-0.22%
MSFT
$521.65
▼-1.53%
MU
$1,035.80
▼-4.80%
NVDA
$230.42
▼-2.97%
SNDK
$1,592.55
▼-5.90%
AMD
$616.74
▼-4.51%
INTC
$106.89
▼-5.51%
SPCX
$161.54
▼-3.61%
META
$719.73
▼-0.22%
MSFT
$521.65
▼-1.53%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:RLMD
Recent news which mentions NASDAQ:RLMD
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q2 2024
August 07, 2024
Tickers
RLMD
Tags
Market News
Earnings Reports
RLMD
From
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024
May 08, 2024
Tickers
RLMD
Tags
Earnings Reports
RLMD
Market News
From
InvestorPlace
RLMD Stock Earnings: Relmada Therapeutics Misses EPS for Q4 2023
March 19, 2024
Tickers
RLMD
Tags
Market News
RLMD
Today's Market
From
InvestorPlace